- Home
- VNDA vs ISPR Comparison
VNDA vs ISPR Comparison
Compare VNDA & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- ISPR
- Stock Information
- Founded
- VNDA 2002
- ISPR 2010
- Country
- VNDA United States
- ISPR United States
- Employees
- VNDA N/A
- ISPR N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- ISPR Medicinal Chemicals and Botanical Products
- Sector
- VNDA Health Care
- ISPR Health Care
- Exchange
- VNDA Nasdaq
- ISPR Nasdaq
- Market Cap
- VNDA 249.4M
- ISPR 126.0M
- IPO Year
- VNDA 2006
- ISPR 2023
- Fundamental
- Price
- VNDA $5.59
- ISPR $2.37
- Analyst Decision
- VNDA Strong Buy
- ISPR Strong Buy
- Analyst Count
- VNDA 2
- ISPR 1
- Target Price
- VNDA $16.50
- ISPR $7.50
- AVG Volume (30 Days)
- VNDA 559.5K
- ISPR 46.7K
- Earning Date
- VNDA 10-29-2025
- ISPR 11-10-2025
- Dividend Yield
- VNDA N/A
- ISPR N/A
- EPS Growth
- VNDA N/A
- ISPR N/A
- EPS
- VNDA N/A
- ISPR N/A
- Revenue
- VNDA $203,467,000.00
- ISPR $127,494,304.00
- Revenue This Year
- VNDA $15.45
- ISPR $60.96
- Revenue Next Year
- VNDA $37.82
- ISPR $23.96
- P/E Ratio
- VNDA N/A
- ISPR N/A
- Revenue Growth
- VNDA 11.78
- ISPR N/A
- 52 Week Low
- VNDA $3.81
- ISPR $2.06
- 52 Week High
- VNDA $5.62
- ISPR $7.47
- Technical
- Relative Strength Index (RSI)
- VNDA 67.24
- ISPR 44.20
- Support Level
- VNDA $5.22
- ISPR $2.31
- Resistance Level
- VNDA $5.62
- ISPR $2.65
- Average True Range (ATR)
- VNDA 0.19
- ISPR 0.17
- MACD
- VNDA 0.00
- ISPR 0.02
- Stochastic Oscillator
- VNDA 94.10
- ISPR 52.54
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.